Shareholders’ Equity (Deficit) (Details Narrative) - USD ($)		3 Months Ended		9 Months Ended	12 Months Ended
	Oct. 13, 2022	Mar. 31, 2023	Mar. 31, 2022	Sep. 30, 2022	Dec. 31, 2022	Apr. 12, 2022	Apr. 06, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period value new issues	$ 30,000,000		$ 0	$ 30,000,000
Share subscriptions payable		$ 1,223,111			$ 591,289
Common stock, shares authorized		299,000,000			299,000,000
Common stock par value		$ 0.0001			$ 0.0001	$ 0.01	$ 0.01
Share based payment award, options, grants in period, gross		810,106			72,500
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based payment award, options, grants in period, gross		100
Preferred stock voting rights		299
Series B Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share based payment award, options, grants in period, gross		100,000
Preferred stock par value		$ 0.0001
Preferred stock voting rights		10,000
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issues		1,195,106
Consultant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period shares issued for services			10,000
Stock issued during period shares issued for services			$ 86,000
Share subscriptions payable			66,329
Number of shares issues		65,000
Consultant [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issues		40,000
Employee Compensation [Member] | Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period value new issues		$ 86,400
Restricted Stock [Member] | Consultant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period value new issues		$ 631,822	$ 1,482